Our experience with tofisopam (grandaxin egypt).
D014151:Anti-Anxiety Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D001569:Benzodiazepines; D004569:Electroencephalography; D005260:Female; D006801:Humans; D009440:Neurasthenia / Q000188:drug therapy*
D014151:Anti-Anxiety Agents; D001569:Benzodiazepines